Several groups including ours have already shown that knockdown6, 22, antibody-mediated blockade23, or pharmacological inhibition6 of PTPRZ reduces the aggressive proliferation and migration properties of glioblastoma cells. This evidence concerns the gene PTPRZ1 and glioblastoma.